ANL 34.12 Increased By ▲ 0.02 (0.06%)
ASC 14.80 Increased By ▲ 0.40 (2.78%)
ASL 24.32 Decreased By ▼ -1.18 (-4.63%)
AVN 91.22 Increased By ▲ 4.67 (5.4%)
BOP 7.79 Increased By ▲ 0.08 (1.04%)
BYCO 10.21 Decreased By ▼ -0.02 (-0.2%)
DGKC 121.50 Decreased By ▼ -0.50 (-0.41%)
EPCL 55.15 Decreased By ▼ -1.45 (-2.56%)
FCCL 24.24 Increased By ▲ 0.49 (2.06%)
FFBL 28.10 Increased By ▲ 0.15 (0.54%)
FFL 16.16 Increased By ▲ 1.01 (6.67%)
HASCOL 9.50 Increased By ▲ 0.14 (1.5%)
HUBC 77.70 Decreased By ▼ -0.17 (-0.22%)
HUMNL 6.47 Increased By ▲ 0.17 (2.7%)
JSCL 20.40 Increased By ▲ 0.55 (2.77%)
KAPCO 40.00 Increased By ▲ 0.55 (1.39%)
KEL 3.82 Increased By ▲ 0.04 (1.06%)
LOTCHEM 15.90 Decreased By ▼ -0.05 (-0.31%)
MLCF 46.15 Decreased By ▼ -0.25 (-0.54%)
PAEL 35.90 Increased By ▲ 1.25 (3.61%)
PIBTL 10.15 Decreased By ▼ -0.04 (-0.39%)
POWER 9.14 Increased By ▲ 0.01 (0.11%)
PPL 85.20 Increased By ▲ 0.20 (0.24%)
PRL 24.30 Increased By ▲ 0.25 (1.04%)
PTC 9.50 Decreased By ▼ -0.11 (-1.14%)
SILK 1.45 Increased By ▲ 0.05 (3.57%)
SNGP 41.40 Increased By ▲ 0.17 (0.41%)
TRG 165.01 Increased By ▲ 11.91 (7.78%)
UNITY 32.65 Increased By ▲ 2.00 (6.53%)
WTL 1.73 Increased By ▲ 0.04 (2.37%)
BR100 4,872 Increased By ▲ 49.63 (1.03%)
BR30 25,586 Increased By ▲ 447.01 (1.78%)
KSE100 45,400 Increased By ▲ 486.21 (1.08%)
KSE30 18,533 Increased By ▲ 170 (0.93%)

Coronavirus
VERY HIGH
Pakistan Deaths
16,453
13724hr
Pakistan Cases
766,882
544524hr
Sindh
273,466
Punjab
273,566
Balochistan
21,000
Islamabad
70,609
KPK
107,309
World

Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use

  • Malaysia began its vaccination drive on Feb. 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.
  • Sinovac signed a deal with Malaysia's Pharmaniaga, which will carry out a fill-and-finish process for the vaccine's distribution in Malaysia, before later manufacturing it locally.
02 Mar 2021

KUALA LUMPUR: Malaysia on Tuesday granted conditional approval for the use of vaccines made by UK firm AstraZeneca and China's Sinovac, just days after launching its nationwide COVID-19 inoculation programme.

Malaysia began its vaccination drive on Feb. 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.

The conditional approval means Malaysia will use the vaccines developed by Astrazeneca and Sinovac, but both firms - along with Pfizer - will be required to provide additional data on rolling submissions to ensure the vaccines' effectiveness and safety, health director-general Noor Hisham Abdullah said in a statement.

Health authorities are also evaluating the COVID-19 vaccine produced by Russia's Gamaleya Research Institute, and the local bottling facility for Sinovac's vaccine, Noor Hisham said.

Sinovac signed a deal with Malaysia's Pharmaniaga, which will carry out a fill-and-finish process for the vaccine's distribution in Malaysia, before later manufacturing it locally.

Malaysia aims to vaccinate at least 80% of its population of about 32 million by February next year.

Last month, the government said it had secured 66.7 million vaccine doses, enough to more than cover its population.